BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Joshuri, the fact that they have ordered a filling machine for Libigel indicates that they have every intention of manufacturing the product. They already have a good R&D program with a number of products in the pipeline. If the FDA identifies a path moving forward on HSDD, Testosterone Restoration and the CV benefit, they may also be contemplating marketing the drug themselves rather then partner. The time awaiting PDUFA approval could be used to put a cracker jack marketing team together. This would eventually maximize their profits.

If this is the case you may not want to move on. In any event based on the FDA feedback any buyout offer would have to make sense.